Indefinite Delivery Contract 36C26325D0016

Award Date 10/1/24
Last Date to Order 9/30/25
Ultimate Awardee
Not listed
Federal Contract Vehicle
Pricing Type
Firm Fixed Price
Legislative Mandate
Not listed
National Interest Action
None
Award Type
Single
Primary Consortia Member
Not listed
Similar IDVs
This federal Indefinite Delivery Contract (IDC) was awarded by the Department of Veterans Affairs (VA) Veterans Health Administration to Cepheid, a for-profit manufacturer of molecular diagnostic solutions, including the GeneXpert testing platform. The single-award IDC, valued up to $1,500,000, is for the procurement of GeneXpert test kits, reagents, and associated maintenance and support services. This IDC enables the VA to continuously acquire Cepheid's molecular diagnostic products and...
The subject contract is an Indefinite Delivery Contract (IDC) awarded by the U.S. Department of Veterans Affairs (VA) to Diasorin Inc., a foreign-owned, for-profit manufacturer of diagnostic testing equipment, assays, reagents, and related services. The contract has a total ceiling value of $291,245.30 and a period of performance through July 14, 2025. Under this IDC, Diasorin will provide the VA's VISN 17 network with its LIAISON XL analyzer reagents for a variety of infectious disease testing,...
The Department of Veterans Affairs Veterans Health Administration (VA VHA) awarded a Blanket Purchase Agreement (BPA) contract to Genmark Diagnostics, Inc., a manufacturer of molecular diagnostic testing equipment and supplies. The BPA, valued at up to $284,856, facilitates the procurement of Genmark's e-sensor and genotyping reagent products to support VA hospitals and clinics, with a period of performance through September 2025. The contract has no set-aside designation. Under this BPA,...
The Department of Veterans Affairs (VA) Veterans Health Administration (VHA) has awarded an indefinite-delivery, indefinite-quantity (IDIQ) service contract to Agena Bioscience, Inc., a for-profit corporation that provides genomic testing equipment, reagents, and services. The contract, valued up to $249,000, is for preventive maintenance and repair services on an Agena Bioscience MassArray system and associated Chip Prep Module located at the Central Arkansas Veterans Healthcare System (CAVHS)....
The Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 23 awarded a single-award indefinite delivery contract to One Lambda, Inc. to provide human leukocyte antigen reagents. The potential value of the contract vehicle is $3.2 million. No set-aside was used. Under the contract, One Lambda has been issued four delivery orders to date for provision of the reagents from facilities in California, Iowa, and West Hills, California. The delivery orders...
The Department of Veterans Affairs (VA) Veterans Integrated Service Network 21 (VISN 21) has awarded an Indefinite Delivery Contract (IDC) to Cepheid, a for-profit manufacturer of molecular diagnostic solutions, to provide reagents and supplies compatible with the GeneXpert Infinity diagnostic analyzer systems used at the VA Southern Nevada Health Care System. The single-award IDC has a $3,000,000 ceiling value and a period of performance from February 2021 through February 2026. Under this...
The Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 23 awarded a single award indefinite-delivery/indefinite-quantity contract to Life Technologies Corporation with a potential value of $400,000.00 and a period of performance through September 2026. Two firm fixed price delivery orders have been issued against this contract to date for tissue typing kits and related services. Delivery Order OP1, valued at $59,928, has a completion date of...
The key products and services being delivered under this federal contract IDV award are Cepheid GeneXpert molecular diagnostic reagents, analyzers, supplies, and associated maintenance and support services. The single-award IDV was issued by the Department of Veterans Affairs (VA) Network Contracting Office 21 with a 5-year period of performance and a $700,000 ceiling value. The contract aims to provide a simplified procurement mechanism for the VA Pacific Islands Health Care System to...
The federal contract IDV award is a single-award Indefinite Delivery Contract (IDC) between the U.S. Department of Veterans Affairs (VA) Veterans Integrated Service Network (VISN) 16 and Cepheid, a for-profit manufacturer of molecular diagnostic solutions. The contract has a ceiling value of $3,426,923.40 and a period of performance extending to June 30, 2029. Under this IDC, Cepheid will provide the VA with a reagent lease for its molecular diagnostic testing equipment and associated...
The Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 17 (VA - VHA VISN 17) awarded an indefinite delivery contract to Roche Diagnostics Corporation to provide GENMARK reagents for diagnostic testing needs. The single award contract has a potential value of $400,000 and a period of performance through July 16, 2028. A firm fixed price delivery order for $63,504 was also issued for one year starting July 17, 2023 for GENMARK reagents to be...
  • 36C26325D0016
    Indefinite Delivery Contract
  • 1
    Federal Contract Awards

The Department of Veterans Affairs (VA), Veterans Integrated Service Network 23 Contracting Office has awarded a single award Indefinite Delivery Contract (IDC) with a ceiling value of $200,000.00 to Gendx Products Inc., a foreign-owned, for-profit biotechnology company. The contract delivers GENDX reagent kits used to perform identification of human leukocyte antigen (HLA) alleles through next generation sequencing (NGS) in support of the Histocompatibility and Immunogenetics Laboratory at the Iowa City VA Health Care System.

The initial task order under the IDC has a firm fixed price of $195,662.00 and a period of performance through September 30, 2025. No set-aside designations were used. The contract was awarded as a sole source under the authority of 41 U.S.C. 3304(a)(1) because Gendx's NGS kits have been validated as compatible with the VA's current in-house equipment. This allows the VA to efficiently continue supporting transplant evaluations and matching processes for veterans through a streamlined procurement of the specialized reagent kits from the sole qualified vendor.

Generated 10/4/24, 9:05 AM